CRBP
Corbus Pharmaceuticals Holdings, Inc.
0.00 (0.00%)7.26USD553K成交股數140M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-16下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | 1.2M+448% | 906K+291% | −177K | −2.7M | 217K | 232K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 31.2M | 19.8M | 18.4M | 20.9M | 15.2M | 15.6M | 10.8M | 6.9M | 5.8M | 7.0M | 6.6M | 4.2M |
| 銷售管理費用 | 5.0M | 4.5M | 3.6M | 3.6M | 4.0M | 4.1M | 4.7M | 4.1M | 3.9M | 3.1M | 2.9M | 3.9M |
| 營業利益 | −36.2M+89% | −24.3M+23% | −22.0M+42% | −24.4M+122% | −19.2M+99% | −19.8M+96% | −15.5M+63% | −11.0M+34% | −9.6M | −10.1M | −9.5M | −8.2M |
| 營業利益率 | – | – | – | – | – | – | -1,304.0% | -1,212.8% | 5,436.3% | 374.9% | -4,372.4% | -3,529.7% |
| 稅後淨利 | −35.0M+98% | −23.0M+35% | −20.6M+49% | −23.3M+133% | −17.7M+156% | −17.0M+112% | −13.8M+37% | −10.0M+14% | −6.9M | −8.0M | −10.1M | −8.8M |
| 淨利率 | – | – | – | – | – | – | -1,159.2% | -1,103.4% | 3,897.4% | 297.7% | -4,632.7% | -3,786.2% |
| 稀釋 EPS | -1.81+26% | -1.23-12% | -1.17+2% | -1.90+111% | -1.44+73% | -1.39-21% | -1.15-49% | -0.90-56% | -0.83 | -1.75 | -2.27 | -2.05 |
| 稀釋股數 | 19.4M | 18.7M | 13.3M | 12.3M | 12.2M | 12.2M | 12.0M | 11.1M | 8.3M | 4.3M | 4.4M | 4.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 23.4M | 25.7M | 28.5M | 27.0M | 20.0M | 18.9M | 19.4M | 23.7M | 14.1M | 13.7M | 11.2M | 8.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 127M | 144M | 168M | 110M | 125M | 140M | 164M | 152M | 126M | 28.3M | 36.3M | 43.7M |
| 有息負債 | – | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.00 | 11.3M |
| 總負債 | 24.7M | 18.1M | 20.7M | 17.4M | 14.1M | 12.8M | 13.7M | 26.4M | 28.8M | 35.2M | 36.0M | 34.2M |
| 股東權益 | 102M | 126M | 148M | 92.1M | 111M | 127M | 150M | 126M | 97.0M | −6.9M | 312K | 9.5M |
| 負債比 | 19.5% | 12.6% | 12.3% | 15.9% | 11.3% | 9.2% | 8.3% | 17.4% | 22.9% | 124.4% | 99.1% | 78.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | 14.1M | 13.7M | 11.2M | −3.0M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −25.6M+56% | – | – | – | −16.4M | – | – | −8.0M | – | – | – |
| 資本支出 | – | 6K | – | – | – | 0.00 | – | – | – | – | – | – |
| 自由現金流 | – | −25.6M+56% | – | – | – | −16.4M | – | – | – | – | – | – |
| 折舊攤銷 | – | 49K | – | – | – | 81K | – | – | 152K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −78.5M | –% | -5.90 | −64.5M |
| FY2024 | – | – | −40.2M | –% | -3.68 | −41.8M |
| FY2023 | −2.9M | – | −44.6M | 1,525.5% | -10.31 | −36.1M |
| FY2022 | 0.00 | -100.0% | −42.3M | –% | -10.15 | −37.6M |
| FY2021 | 882K | -77.6% | −45.6M | -5,176.4% | -11.15 | −48.2M |
| FY2020 | 3.9M | -89.1% | −111M | -2,826.1% | -1.42 | −100M |
| FY2019 | 36.1M | +649.5% | −71.5M | -197.7% | -1.12 | −48.5M |
| FY2018 | 4.8M | – | −55.7M | -1,154.5% | -0.98 | −32.4M |